Trial Profile
A Study to Evaluate the Efficacy, Safety and Tolerability of Atomoxetine in Patients with Parkinson's Disease and Non Levodopa Responsive Freezing of Gait
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 16 Dec 2015 New trial record